RotaTeq

RotaTeq Description

vaccine, rotavirus

Manufacturer:

Merck Sharp & Dohme
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Description
Each 2-mL dose contains the following human-bovine rotavirus reassortants: G1, G2, G3, G4 and P1[8]. The minimum dose levels of the reassortants are: G1 2.2 x 106 infectious units, G2 2.8 x 106 infectious units, G3 2.2 x 106 infectious units, G4 2 x 106 infectious units and P1[8] 2.3 x 106 infectious units.
The reassortants are propagated in Vero cells using standard tissue culture techniques in the absence of antifungal agents.
The reassortants are suspended in a buffered stabilizer solution. Each vaccine dose also contains the following inactive ingredients: Sucrose, sodium citrate, monobasic sodium phosphate monohydrate, sodium hydroxide, polysorbate 80 and also culture media. There are no preservatives or thimerosal present.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in